6-week oral administration of a mixture of beeswax alcohols (D-002) improves OA symptoms .
This report has been verified
by one or more authors of the
original publication.
Evaluation of the effect of D-002, a mixture of beeswax alcohols, on osteoarthritis symptoms
Korean J Intern Med. 2014 Mar;29(2):191-202. doi: 10.3904/kjim.2014.29.2.191. Epub 2014 Feb 27.60 patients with diagnosed osteoarthritis of the knee, hip, or fingers were randomized to receive an oral tablet once daily of either D-002 (50 mg) or placebo for a total of 6 weeks. At week 3, if no improvement was observed, the dose was increased to two tablets per day (daily dose of 100 mg). The purpose of this study was to determine the effect of D-002 - a combination of beeswax alcohols - on osteoarthritis symptom reduction. Results indicated that Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores for pain, stiffness and function, as well as total WOMAC scores and VAS pain were improved to a significantly higher degree in the D-002 group compared to the placebo group at study completion.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
